NCT06701422 Targeting Cervical Epidural Spinal Cord Stimulation for Functional Recovery
| NCT ID | NCT06701422 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | Cervical Spinal Cord Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2024-12-06 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2024-12-06 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The proposed study seeks to understand how the cervical spinal cord should be stimulated after injury through short-term physiology experiments that will inform a preclinical efficacy trial. The purpose of this study is to determine which cervical levels epidural electrical stimulation (EES) should target to recruit arm and hand muscles effectively and selectively in spinal cord injury (SCI).
Eligibility Criteria
Inclusion Criteria: •Clinical indication for cervical spine surgery. Exclusion criteria: •Stimulation devices in the neck or chest (e.g., vagal nerve stimulation, cardiac patients with pacemakers)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06701422 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cervical Spinal Cord Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06701422 currently recruiting?
Yes, NCT06701422 is actively recruiting participants. Contact the research team at jbc28@cumc.columbia.edu for enrollment information.
Where is the NCT06701422 trial being conducted?
This trial is being conducted at New York, United States, New York, United States.
Who is sponsoring the NCT06701422 clinical trial?
NCT06701422 is sponsored by Columbia University. The trial plans to enroll 36 participants.